RxDoctor Payments Data

Cassidy Wright

Physician Assistant · Jackson, TNNPI 1902549249

Payments from drug & device makers

$1,564in general payments, 2019–2025

Across 69 payments — averaging $22.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$415
  • GSK$309
  • United Therapeutics Corporation$201
  • Mylan Specialty L.p.$118
  • Boehringer Ingelheim$75
  • Baxter Healthcare$64
  • plus $382 from 9 others

What the payments were for

  • Food & beverage$1,54799%
  • Education$161%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,564 in reported general payments places this provider in the 75th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$3,615
Medicare patients
31
Services billed
53

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter74$52,047
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$12,123
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr19$8,350
Stiolto RespimatTiotropium Br/Olodaterol Hcl14$6,588
Varenicline Tartrate11$1,512
Albuterol Sulfate HfaAlbuterol Sulfate50$1,116
Prednisone17$59

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta$309$60,39793 claims
AstraZenecaBreztri Aerosphere$415$12,12315 claims
Boehringer IngelheimStiolto Respimat$75$6,58814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Jackson

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →